Our Services
Medical Information
Helpful Resources
Published on: 4/8/2026
Hydroxychloroquine is generally safe and effective for autoimmune conditions in women over 40 when correctly dosed and monitored. Key points include keeping the dose at or below 5 mg/kg of actual body weight, getting a baseline eye exam and annual screening after 5 years to help prevent retinal toxicity, and watching for rare heart rhythm issues, low blood sugar, and common GI upset.
Next steps include confirming weight based dosing, scheduling eye exams, reviewing other medicines and heart or kidney risks with your clinician, considering menopause symptom overlap, and not stopping the drug without medical advice; there are several factors to consider for your personal plan, and the complete details that could affect your decisions are below.
If you're a woman over 40 and have been prescribed hydroxychloroquine, you may have questions about safety, long-term effects, and how it fits into this stage of life. That's completely reasonable.
Hydroxychloroquine has been used for decades and remains an important medication for several autoimmune and inflammatory conditions. When taken correctly and monitored properly, it is generally considered safe and effective. However, women over 40 have unique health considerations — including vision changes, heart health, and peri- or post-menopausal shifts — that make informed use especially important.
Here's what you need to know.
Hydroxychloroquine is a prescription medication originally developed to prevent and treat malaria. Today, it's most commonly used to treat autoimmune diseases such as:
It works by calming an overactive immune system. Unlike steroids, it does not suppress the immune system broadly. Instead, it modulates immune activity in a more targeted way.
For many women with autoimmune disease, hydroxychloroquine can:
It is often used long term.
Autoimmune diseases are significantly more common in women — especially between ages 30 and 60. That means many women begin or continue hydroxychloroquine treatment during their 40s and beyond.
At the same time, this life stage often brings:
Understanding how hydroxychloroquine fits into this bigger picture is essential.
According to decades of clinical data and guidelines from major rheumatology and ophthalmology organizations, hydroxychloroquine is generally safe when used at recommended doses and properly monitored.
However, no medication is risk-free.
The most important safety considerations include:
The most serious long-term risk of hydroxychloroquine is retinal toxicity, which can affect vision.
Key facts:
What to do:
Early detection prevents vision loss. With proper screening, serious complications are uncommon.
Rarely, hydroxychloroquine can affect heart rhythm (QT prolongation) or lead to cardiomyopathy after very long-term use.
Risk is higher if you:
Most women tolerate hydroxychloroquine without cardiac issues. Still, if you experience:
You should speak to a doctor promptly.
Common but usually mild:
Taking hydroxychloroquine with food often reduces these effects.
Hydroxychloroquine can lower blood sugar. For women with diabetes or prediabetes, this may actually be helpful — but monitoring is important.
Watch for symptoms of low blood sugar:
If these occur, speak to a doctor.
Hormonal changes during perimenopause and menopause can overlap with autoimmune symptoms, including:
It can sometimes be difficult to tell whether symptoms are due to autoimmune disease, menopause, or both.
If you're experiencing symptoms and aren't sure whether they're related to your autoimmune condition or hormonal changes, our free Peri-/Post-Menopausal Symptoms checker can help you identify what may be contributing to how you're feeling and guide your conversation with your healthcare provider.
Hormone therapy and hydroxychloroquine can often be used together safely, but this should always be coordinated through your doctor.
Proper dosing is critical for safety.
Current expert guidelines recommend:
Women who lose weight or gain weight significantly should have their dosage reassessed. Kidney function should also be monitored, especially after 60.
Never adjust your hydroxychloroquine dose on your own.
If you are taking hydroxychloroquine long term, ask your doctor about:
Many women take hydroxychloroquine safely for decades with appropriate monitoring.
While serious side effects are rare, you should seek urgent medical care if you experience:
Do not delay. Speak to a doctor immediately if something feels serious or life-threatening.
For many women with lupus or rheumatoid arthritis, hydroxychloroquine:
Stopping hydroxychloroquine without medical guidance can lead to disease flare — which may pose greater risk than the medication itself.
The goal is not to fear the medication, but to use it wisely.
If you are currently taking hydroxychloroquine:
If you are considering starting hydroxychloroquine:
Hydroxychloroquine remains one of the most important and well-studied medications for autoimmune disease. For women over 40, it can be both protective and life-improving when used correctly.
The key is balance:
If you notice new symptoms — whether related to autoimmune disease, menopause, heart health, or vision — do not ignore them. Speak to a doctor about anything that could be serious or life threatening.
With the right oversight, hydroxychloroquine can continue to be a safe and valuable part of your health plan well into midlife and beyond.
(References)
* Melles RB, Marmor MF. The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapy. JAMA Ophthalmol. 2014 Dec;132(12):1453-60. doi: 10.1001/jamaophthalmol.2014.3562. PMID: 25299491.
* Chiu YM, Cheng TT, Wu CY, Huang W, Liao WL, Hsu YP, Chu PH. Hydroxychloroquine use and the risk of cardiovascular events in patients with rheumatoid arthritis: a nationwide population-based cohort study. Arthritis Res Ther. 2021 Jul 15;23(1):194. doi: 10.1186/s13075-021-02573-0. PMID: 34266405; PMCID: PMC8281315.
* Durcan L, Clarke G, Meaney JF, MacMorrow M, O'Regan A, McCormack C, Molloy E, Kenny D, Murray N, FitzGerald O, Ryan JG. Guidelines for the monitoring of antimalarial drug toxicity in rheumatology: an update. Rheumatology (Oxford). 2020 Jan 1;59(1):1-12. doi: 10.1093/rheumatology/kez220. PMID: 31270487.
* Wang H, Zhu C, Xie W, Ding J, Zhang S, Zheng H, Li T, Gu Z. Hydroxychloroquine treatment is associated with decreased risk of osteoporotic fractures in patients with rheumatoid arthritis. Osteoporos Int. 2023 Feb;34(2):333-342. doi: 10.1007/s00198-022-06597-x. Epub 2022 Oct 28. PMID: 36306001.
* Kowalski ML, Ziółkowski M, Pasierski T. Safety of hydroxychloroquine-Current state of knowledge. Adv Dermatol Allergol. 2022 Feb;39(1):1-10. doi: 10.5114/ada.2021.111956. Epub 2021 Nov 16. PMID: 35211025; PMCID: PMC8858760.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.